文献速递核素与放射性配体治疗放射性药物与辐射防护

99mTc-MAA SPECT/CT 计算肺分流分数用于 90Y 微球选择性内放射治疗

Lung shunt fraction calculation using 99mTc-MAA SPECT/CT imaging for 90Y microsphere selective internal radiation therapy of liver tumors.
PubMed 文献 · EJNMMI Res · 2021-09-28

本研究在 85 例拟接受 90Y SIRT 的肝肿瘤患者中比较平面显像与 SPECT/CT 计算肺分流分数(LSF)的差异。平面显像 LSF 均值 8.5% 显著高于 SPECT/CT 的 4.6%(配对 t 检验,α=0.05),且平面显像估算的肺平均吸收剂量显著更高(P<0.005)。体模实验显示 SPECT/CT 计算 LSF 的平均高估值(6%)低于平面显像(26%)。

要点

  • 平面显像计算 LSF 在 81/85 例中高于 SPECT/CT,均值 8.5% vs 4.6%。
  • 接受 SIRT 患者中,平面显像估算的肺平均吸收剂量显著高于 SPECT/CT(P<0.005)。
  • 体模实验示 SPECT/CT 计算 LSF 平均高估 6%,平面显像高估 26%。

核心结论

  • 平面显像计算 LSF 可显著高估,SPECT/CT 结合合适分割工具更准确,有助于优化 90Y SIRT 治疗计划并确保肺剂量不超过标准安全阈值。

研究设计与样本

  • 回顾性分析 85 例连续拟接受 90Y SIRT 的肝肿瘤患者,比较平面显像与 SPECT/CT 两种方法计算的 LSF 及估算肺平均吸收剂量。
  • 另用可变 99mTc 活度浓度的拟人躯干体模按标准患者协议重复实验,比较两种方法计算 LSF 的准确性。

主要发现

  • 平面显像 LSF 在 81/85 例中高于 SPECT/CT,均值分别为 8.5% 与 4.6%,配对 t 检验差异有统计学意义(α=0.05)。
  • 接受 SIRT 的患者中,平面显像估算的肺平均吸收剂量显著高于 SPECT/CT(t 检验,P<0.005)。
  • 体模实验中 SPECT/CT 计算 LSF 的平均高估值为 6%,平面显像为 26%。

关键数值与推荐

  • LSF 计算采用平面前后位几何均值法(基于肝与肺 ROI)或 SPECT/CT 胸腹部图像分割法。
  • 体模实验使用可变 99mTc 活度浓度的拟人躯干体模,按标准患者协议采集。

临床怎么用

  • 在 90Y SIRT 治疗计划中,建议采用 99mTc-MAA SPECT/CT 替代平面显像计算 LSF,以减少高估并优化治疗计划,同时确保肺剂量不超过标准安全阈值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: 99mTc-macroaggregated albumin (99mTc-MAA) scintigraphy is utilized in treatment planning for Yttrium-90 (90Y) Selective Internal Radiation Therapy (SIRT) of liver tumors to evaluate hepatopulmonary shunting by calculating the lung shunt fraction (LSF). The purpose of this study was to evaluate if LSF calculation using SPECT/CT instead of planar gamma camera imaging is more accurate and if this can potentially lead to more effective treatment planning of hepatic lesions while avoiding excessive pulmonary irradiation. RESULTS: LSF calculation was obtained using two different methodologies in 85 cases from consecutive patients intended to receive 90Y SIRT. The first method was based on planar gamma camera imaging in the anterior and posterior views with geometric mean calculation of the LSF from regions of interest of the liver and lungs. The second method was based on segmentation of the liver and lungs from SPECT/CT images of the thorax and abdomen. The differences in planar imaging versus SPECT/CT derived LSF values along with the estimated absorbed lung mean dose (LMD) were evaluated. The LSF values were higher in planar imaging versus SPECT/CT in 81/85 cases, with a mean value of 8.5% vs. 4.6% respectively; the difference was statistically significant using a paired t-test (alpha = 0.05). In those patients who received SIRT, the estimated absorbed LMD calculated with planar imaging was significantly higher than with SPECT/CT (t-test, P < 0.005). Repeated phantom experiments using an anthropomorphic torso phantom with variable 99mTc activity concentrations for the liver and lungs were performed with the standard patient protocol, demonstrated improved accuracy of the LSF calculation based on SPECT/CT than planar imaging (mean overestimated value of 6% vs. 26%). CONCLUSIONS: This study demonstrates that LSF calculation using planar imaging can be significantly overestimated while calculation using SPECT/CT imaging and appropriate segmentation tools can be more accurate. Minimizing the errors in obtaining the LSF can lead to more effective 90Y SIRT treatment planning for hepatic tumors while ensuring the lung dose will not exceed the standard acceptable safety thresholds.

来源:EJNMMI Res,查看原文。版权归原作者所有。

引用

  1. Georgiou MF, Kuker RA, Studenski MT, et al. Lung shunt fraction calculation using 99mTc-MAA SPECT/CT imaging for 90Y microsphere selective internal radiation therapy of liver tumors. EJNMMI Res. 2021. PMID: 34585259. doi:10.1186/s13550-021-00837-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。